PTGS2 and adenocarcinoma: Baltazar et al. evaluated 130 cervical cancer patients for COX-2 and EGFR expression and found that adenocarcinomas (ACC) had higher levels of COX-2 expression than adenosquamous carcinomas (ASC) [9].